First Quadrant’s Halozyme HALO Stock Holding History

First Quadrant’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-16,900	Closed	-$262K	–	594
2019 Q3	$262K	Hold	16,900	–	–	0.02%	381
2019 Q2	$290K	Hold	16,900	–	–	0.02%	468
2019 Q1	$272K	Sell	16,900 -24,787	-59%	-$402K	0.02%	451
2018 Q4	$610K	Sell	41,687 -11,344	-21%	-$181K	0.05%	322
2018 Q3	$964K	Sell	53,031 -47,902	-47%	-$839K	0.02%	392
2018 Q2	$1.7M	Buy	100,933 +76,271	+309%	+$1.44M	0.03%	348
2018 Q1	$483K	Buy	24,662 +19,905	+418%	+$385K	0.01%	489
2017 Q4	$96K	Buy	+4,757	New	+$87.5K	﹤0.01%	799

Other funds holding HALO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

First Quadrant's HALO Position: Q4 2019 in Review

First Quadrant sold out of Halozyme (HALO) in Q4 2019, closing a stake of 16,900 shares — an estimated $262K sold.

First Quadrant first reported a position in HALO in Q4 2017 and held it in 8 quarters. The position peaked at $1.7M in Q2 2018. 224 funds tracked by Wall St. Rank hold HALO as of Q4 2019.

First Quadrant reported no remaining Halozyme position as of Q4 2019 after selling out during the quarter.
First Quadrant sold 16,900 Halozyme shares in Q4 2019, an estimated $262K.
First Quadrant first reported a position in Halozyme in Q4 2017 and held it in 8 quarters.
First Quadrant's Halozyme position peaked at $1.7M in Q2 2018.
224 funds tracked by Wall St. Rank held Halozyme as of Q4 2019.

Based on First Quadrant's 13F filing for Q4 2019, filed 28 Jan 2020.